Migalastat
Back to searchMolecule Structure
Scientific Name
Migalastat
Description of the Drug
Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05018
http://www.drugbank.ca/drugs/DB05018
Brand Name(s)
At-1001, gr-181314a, Galafold
Company Owner(s)
Amicus Therapeutics Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Alpha-galactosidase A | SINGLE PROTEIN | STABILISER | CHEMBL2524 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1479364 | ||
DrugBank | DB05018 | ||
PubChem: Thomson Pharma | 15066543 | 15321768 | |
PubChem | 176077 | ||
Nikkaji | J370.938H | ||
PDBe | DGJ | ||
BindingDB | 50163440 | ||
DrugCentral | 5110 | ||
Guide to Pharmacology | 10200 | ||
rxnorm | GALAFOLD | MIGALASTAT | MIGALASTAT HYDROCHLORIDE |
ChEBI | 135923 | ||
ZINC | ZINC000001636704 |